407 related articles for article (PubMed ID: 19764431)
41. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
42. Association Between Genetic Polymorphisms and Pain Sensitivity in Patients with Hip Osteoarthritis.
Olesen AE; Nielsen LM; Feddersen S; Erlenwein J; Petzke F; Przemeck M; Christrup LL; Drewes AM
Pain Pract; 2018 Jun; 18(5):587-596. PubMed ID: 29055075
[TBL] [Abstract][Full Text] [Related]
43. Contribution of genetic variants to pain susceptibility in Parkinson disease.
Greenbaum L; Tegeder I; Barhum Y; Melamed E; Roditi Y; Djaldetti R
Eur J Pain; 2012 Oct; 16(9):1243-50. PubMed ID: 22473870
[TBL] [Abstract][Full Text] [Related]
44. Variation in the COMT gene: implications for pain perception and pain treatment.
Andersen S; Skorpen F
Pharmacogenomics; 2009 Apr; 10(4):669-84. PubMed ID: 19374521
[TBL] [Abstract][Full Text] [Related]
45. Pharmacogenomics in Pain Management.
Saba R; Kaye AD; Urman RD
Anesthesiol Clin; 2017 Jun; 35(2):295-304. PubMed ID: 28526150
[TBL] [Abstract][Full Text] [Related]
46. [Gene polymorphisms in ATP (purinergic) receptors and pain sensitivity].
Ide S; Minami M; Ikeda K
Masui; 2009 Sep; 58(9):1122-9. PubMed ID: 19764435
[TBL] [Abstract][Full Text] [Related]
47. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
[TBL] [Abstract][Full Text] [Related]
48. Association between Gene Polymorphisms and Pain Sensitivity Assessed in a Multi-Modal Multi-Tissue Human Experimental Model - An Explorative Study.
Nielsen LM; Olesen AE; Sato H; Christrup LL; Drewes AM
Basic Clin Pharmacol Toxicol; 2016 Oct; 119(4):360-6. PubMed ID: 27061127
[TBL] [Abstract][Full Text] [Related]
49. Complicated pain management in a CYP450 2D6 poor metabolizer.
Foster A; Mobley E; Wang Z
Pain Pract; 2007 Dec; 7(4):352-6. PubMed ID: 17986163
[TBL] [Abstract][Full Text] [Related]
50. Overview of genetic analysis of human opioid receptors.
Spampinato SM
Methods Mol Biol; 2015; 1230():3-12. PubMed ID: 25293312
[TBL] [Abstract][Full Text] [Related]
51. The consequence of concomitantly present functional genetic variants for the identification of functional genotype-phenotype associations in pain.
Lötsch J; Flühr K; Neddermayer T; Doehring A; Geisslinger G
Clin Pharmacol Ther; 2009 Jan; 85(1):25-30. PubMed ID: 18548001
[TBL] [Abstract][Full Text] [Related]
52. The genetic influences on oxycodone response characteristics in human experimental pain.
Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J
Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474
[TBL] [Abstract][Full Text] [Related]
53. Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study.
Agulló L; Aguado I; Muriel J; Margarit C; Gómez A; Escorial M; Sánchez A; Fernández A; Peiró AM
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445931
[TBL] [Abstract][Full Text] [Related]
54. Pain, analgesia and genetics.
Muralidharan A; Smith MT
J Pharm Pharmacol; 2011 Nov; 63(11):1387-400. PubMed ID: 21988420
[TBL] [Abstract][Full Text] [Related]
55. How individual sensitivity to opiates can be predicted by gene analyses.
Ikeda K; Ide S; Han W; Hayashida M; Uhl GR; Sora I
Trends Pharmacol Sci; 2005 Jun; 26(6):311-7. PubMed ID: 15925706
[TBL] [Abstract][Full Text] [Related]
56. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
Ho KWD; Wallace MR; Staud R; Fillingim RB
Pharmacogenomics J; 2020 Jun; 20(3):471-481. PubMed ID: 31806881
[TBL] [Abstract][Full Text] [Related]
57. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
58. [M1-OPIOID RECEPTOR AND CATECHOL-O-METILTRANSFERASE GENES POLYMORPHISM EFFECTS ON PERIOPERATIVE PSYCHOLOGICAL CONDITION OF THE PATIENTS AND THE EFFECTIVENESS OF POSTOPERATIVE ANALGESIA WITH OPIOIDS].
Potapov AL; Boiarkina AV
Anesteziol Reanimatol; 2015; 60(3):48-51. PubMed ID: 26415297
[TBL] [Abstract][Full Text] [Related]
59. Genetic variability and clinical efficacy of morphine.
Klepstad P; Dale O; Skorpen F; Borchgrevink PC; Kaasa S
Acta Anaesthesiol Scand; 2005 Aug; 49(7):902-8. PubMed ID: 16045647
[TBL] [Abstract][Full Text] [Related]
60. Reviewing pharmacogenetics to advance precision medicine for opioids.
Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
